Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false
creator	label written parliamentary question
publisher
tabling member	label written parliamentary question

Search

1127427

	human indexable
	published
	registered interest
	answer date	04/06/2019
	date	20/05/2019
	date tabled	20/05/2019
	ddp created	20/05/2019 20:02:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/05/2019 20:05:44 04/06/2019 14:11:05
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL15838
	legislature	25277
	parliament number	57
	question first answered	04/06/2019 13:39:39
	question text	To ask Her Majesty's Government what discussions they intend to have, if any, with pharmaceutical companies about how the environmental damage caused by asthma inhalers may be reduced.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15838
	type	WrittenParliamentaryQuestion
	uin	HL15838
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1127428

	human indexable
	published
	registered interest
	answer date	04/06/2019
	date	20/05/2019
	date tabled	20/05/2019
	ddp created	20/05/2019 20:02:50
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 16:05:07 04/06/2019 14:14:06
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL15839
	legislature	25277
	parliament number	57
	question first answered	04/06/2019 13:42:39
	question text	To ask Her Majesty's Government what assessment they have made of the sufficiency of the progress made by NICE on working with clinicians and industry to promote greater use of asthma inhalers with low global warming potential.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15839
	type	WrittenParliamentaryQuestion
	uin	HL15839
	version	2
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1127995

	human indexable
	published
	registered interest
	answer date	05/06/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 21:46:05
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 21:55:30 05/06/2019 14:49:04
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL15880
	legislature	25277
	parliament number	57
	question first answered	05/06/2019 14:17:11
	question text	To ask Her Majesty's Government what assessment they have made of the proportion of inhaler users who are (1) not getting their inhaler technique checked, and (2) not using their inhaler properly.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15880
	type	WrittenParliamentaryQuestion
	uin	HL15880
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1127996

	human indexable
	published
	registered interest
	answer date	05/06/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 21:46:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 21:55:33 05/06/2019 14:49:02
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL15881
	legislature	25277
	parliament number	57
	question first answered	05/06/2019 14:17:11
	question text	To ask Her Majesty's Government what assessment they have made of the impact on patients of not using their asthma inhalers correctly.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15881
	type	WrittenParliamentaryQuestion
	uin	HL15881
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1127997

	human indexable
	published
	registered interest
	answer date	05/06/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 21:46:07
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 21:55:34 05/06/2019 14:49:01
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL15882
	legislature	25277
	parliament number	57
	question first answered	05/06/2019 14:17:11
	question text	To ask Her Majesty's Government what action they are taking to introduce national guidelines to ensure that everyone with asthma should get their inhaler technique checked annually as part of their asthma review.
	session	2017/19
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15882
	type	WrittenParliamentaryQuestion
	uin	HL15882
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1176204

	human indexable
	published
	registered interest
	answer date	18/02/2020
	date	04/02/2020
	date tabled	04/02/2020
	ddp created	04/02/2020 21:26:37
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	04/02/2020 21:36:13 12/02/2020 18:12:02
	hansard heading	Asthma: Medical Equipment
	house id	2
	identifier	HL1324
	legislature	25277
	parliament number	58
	question first answered	12/02/2020 17:40:47
	question text	To ask Her Majesty's Government what assessment they have made of the study from the University of Cambridge The costs of switching to low global-warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England, published on 30 October 2019, which found that switching to more environmentally friendly asthma inhalers could achieve large cabon saving and reduce drug costs.
	session	2019/20
	session number	1
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2019/20 HL1324
	type	WrittenParliamentaryQuestion
	uin	HL1324
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066
	publisher	25277
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath written parliamentary question 1148064 1148065 1148066

1128929

	human indexable
	published
	registered interest
	answer date	05/06/2019
	date	03/06/2019
	date tabled	03/06/2019
	ddp created	03/06/2019 16:29:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/06/2019 16:56:25 11/06/2019 17:14:04
	hansard heading	Asthma: Medical Equipment
	house id	1
	identifier	259040
	legislature	25259
	parliament number	57
	question first answered	11/06/2019 16:42:08
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all asthma inhalers are recycled.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 259040
	type	WrittenParliamentaryQuestion
	uin	259040
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	1436 label Biography information for Paul Farrelly written parliamentary question 1147852 1148188 1148249
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly written parliamentary question 1147852 1148188 1148249

1224467

	human indexable
	published
	registered interest
	answer date	16/07/2020
	date	14/07/2020
	date tabled	14/07/2020
	ddp created	14/07/2020 18:47:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/07/2020 19:23:36 03/08/2020 12:05:13
	hansard heading	Asthma: Medical Equipment
	house id	1
	identifier	73900
	legislature	25259
	parliament number	58
	question first answered	03/08/2020 11:33:27
	question text	To ask the Secretary of State for Health and Social Care, what assessment he made of the implications of reliever inhalers for the carbon footprint of propellant inhalers when establishing the metric in the Primary Care Network Contract to tackle that footprint; and for what reason reliever inhalers were excluded from that metric.
	session	2019/21
	session number	1
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	title	House of Commons Tabled Parliamentary Question 2019/21 73900
	type	WrittenParliamentaryQuestion
	uin	73900
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731
	publisher	25259
	tabling member	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731

1230079

	human indexable
	published
	registered interest
	answer date	03/09/2020
	date	01/09/2020
	date tabled	01/09/2020
	ddp created	01/09/2020 21:43:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	01/09/2020 21:45:16 14/09/2020 18:05:13
	hansard heading	Asthma: Medical Equipment
	house id	1
	identifier	83862
	legislature	25259
	parliament number	58
	question first answered	14/09/2020 17:34:00
	question text	To ask the Secretary of State for Health and Social Care, what recent what comparative assessment he has made of the (a) availability and (b) level of use of short-acting beta agonist (SABA) blue inhalers for the treatment of asthma in the UK and internationally.
	session	2019/21
	session number	1
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	title	House of Commons Tabled Parliamentary Question 2019/21 83862
	type	WrittenParliamentaryQuestion
	uin	83862
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731
	publisher	25259
	tabling member	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731

1230080

	human indexable
	published
	registered interest
	answer date	03/09/2020
	date	01/09/2020
	date tabled	01/09/2020
	ddp created	01/09/2020 21:43:50
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	01/09/2020 21:45:20 14/09/2020 18:05:11
	hansard heading	Asthma: Medical Equipment
	house id	1
	identifier	83863
	legislature	25259
	parliament number	58
	question first answered	14/09/2020 17:34:00
	question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of the (a) availability and (b) level of use of short-acting beta agonist (SABA, blue inhalers) for the treatment of asthma in each of the regions of the England.
	session	2019/21
	session number	1
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	title	House of Commons Tabled Parliamentary Question 2019/21 83863
	type	WrittenParliamentaryQuestion
	uin	83863
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction
	creator	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731
	publisher	25259
	tabling member	4471 label Biography information for Rachael Maskell written parliamentary question 1147720 1147721 1147731